A first Belgian study on psilocybine treatment in the Belgian medical landscape, a new therapeutic approach appears, aroused both curiosity and hope. THE CHU Brugmann in Brussels conducts a clinical study in Belgium on psilocybin, a substance present in hallucinogenic mushrooms. This study aims to deal with psychiatric problems such as alcoholism. This study represents a major advance in medical research in Belgium. It opens up new perspectives for the treatment of mental disorders resistant to conventional therapies. But what exactly do we know about this controversial substance and how could it revolutionize our approach to certain mental illnesses?
Recently, the scientific community was closely interested in the therapeutic potential of psilocybin. Studies have shown that treatment can be effective in dealing with different mental health problems. These problems include depression, anxiety linked to terminal cancer and disorders linked to the consumption of substances, such as alcoholism.
The clinical study conducted at the Brugmann CHU is led by a multidisciplinary team of experienced researchers and clinicians. This team combines expertise in psychiatry, neurology, psychology and pharmacology, guaranteeing a holistic and rigorous approach to research.
Objectives of the clinical study for the treatment ofalcoholism
The main goal of this study is to see if psilocybin can help people dependent on alcohol to avoid relapses. Researchers also hope to better understand the mechanisms of action of psilocybin on the brain and its impact on addictive behavior.
Study methodology
The target clinical research of patients diagnosed with alcohol dependence, which has already followed conventional treatments without lasting success. The selection criteria are rigorous to guarantee the safety of participants and the validity of the results.
Processing protocol
The study protocol provides for the administration of psychedelic substances in a controlled and secure framework. The processing sessions are supervised by qualified health professionals and are accompanied by psychotherapeutic support before, during and after psychedelic experience.
Monitoring and evaluation of results
Participants are subject to close follow -up over several months after treatment. Researchers study the frequency and intensity of drinking desires, quality of life, mood and overall functioning of patients. They analyze these different aspects to better understand the situation of patients.
Focus on the treatment of alcoholism
Alcoholism represents a major public health challenge in Belgium and in the world. Its consequences on physical and mental health, as well as on the social and economic level, are considerable. Finding effective treatments to help people with alcohol addiction is therefore a priority.
Current therapeutic approaches and their limits
Current alcoholism treatments generally include a combination of behavioral therapies, drugs and support groups. However, relapse rates remain high, highlighting the need for new therapeutic approaches.
Why could psilocybin be a new weapon against alcoholism?
A study American -conducted on 95 participants showed that psilocybin, associated with therapy, could significantly reduce alcohol consumption and desires to drink in people with alcohol.
A reassuring danger profile
Compared to other psychoactive substances, psilocybin has a relatively low danger profile. Depending on international rankings, it is among the least dangerous substances, far behind alcohol which, ironically, is legally accessible.
There Dr Catherine Hanak, psychiatrist and addiction specialist, insists on this point: "It would seem that alcohol is among the most dangerous, even the most dangerous; while certain substances, which are however illegal seem to present few dangers, such as hallucinogenic, the least dangerous of which would be psilocybin".
Psilocybin, a new therapeutic approach
Faced with the difficulties encountered in the treatment of alcoholism and high relapse rates, psilocybin offers the hope of a new therapeutic approach. "It is in this context that the product is tested in a context of rebirth of psychedelic medicine, of the use of psychedelic products to try to help people in their psychic, mental, psychiatric difficulties", explains Dr Hanak.
To read: Psilocybine mushrooms: Nîmes University Hospital, a pioneer experimentation…
Conclusion
The study on psilocybin conducted by the Brugmann CHU is a major advance in Belgian medical research. It opens the way to new promising approaches to the treatment of alcoholism and other mental disorders, while emphasizing the importance of rigorous and prudent research to guarantee the safety and efficiency of these new therapies.
Faq
1. Is Psilocybine legal in Belgium?
No, psilocybin remains an illegal substance in Belgium. The clinical study benefits from special authorization for medical research purposes.
2. What are the risks associated with the use of psilocybin?
Risks may include negative psychological reactions, a temporary increase in anxiety or blood pressure. This is why the study is conducted in a strictly controlled medical framework.
3. How long does psilocybine treatment last?
The study protocol with psilocybin has not been revealed, but patients generally receive supervised sessions followed by therapeutic monitoring.
4. Does this study mean that psilocybin will soon be available as a treatment in Belgium?
No, the study is only a first step. Numerous additional research and regulatory changes would be necessary before possible approval as treatment.
5. Can we participate in this clinical study?
Participation in the study is subject to strict criteria. Those interested should contact the Psychiatry Department of CHU Brugmann directly for more information.
Important : It is important to note that research on psilocybin for the treatment of alcoholism is still underway and that other studies are necessary to confirm the preliminary results and determine its long -term effectiveness and safety. The use of psilocybin in this context must imperatively be under strict medical supervision.
Quotes: [1] https://www.lesperispeliste.be/fr/actualites/une-premiere-teude-clinique-belge-sur-un-trementament-a-base-de-champignons-hallucinogenes.html [2] HTTPS: //www.rtbf.be/article/alcoolism-eviter-les-rechutes-grace-aux-champignons-hallucinogenes-un-prier-essai-clinique-en-Belgique-11398660 [3] https: //www.lavenir. Net/Actu/2024/07/02/Des-Champignons-Hallucinogenes-A-leude-AuPres-Dalcolo-dependants-UHZVX6VUUNEG5LG2E2V7RBCONQ/
